Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

China · Delayed Price · Currency is CNY

13.76

-0.13 (-0.94%)

May 20, 2026, 12:49 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Industry			2.10B	1.87B	-	-		-
Industry Growth			12.27%	-	-	-		-
Commodity Circulation (Commercial)			46.19M	48.85M	43.87M	43.98M		34.02M
Commodity Circulation (Commercial) Growth			-5.45%	11.35%	-0.25%	-		-
Other Business			27.41M	42.15M	18.38M	7.93M		7.39M
Other Business Growth			-34.98%	129.37%	131.74%	-		-
Chinese Patent Medicine (Industry)			-	-	1.59B	1.43B		1.44B
Chinese Patent Medicine (Industry) Growth			-	-	11.49%	-		-5.62%
Other (Industrial)			-	-	88.19M	87.72M		98.70M
Other (Industrial) Growth			-	-	0.54%	-		15.60%
Total			2.17B	1.96B	1.74B	1.57B		1.58B
Total Growth			10.81%	12.55%	11.15%	-		-1.94%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China			2.16B	1.95B	1.73B	1.55B		1.57B
China Growth			10.81%	12.52%	11.80%	-		-2.12%
Overseas			12.35M	11.12M	9.45M	17.51M		14.76M
Overseas Growth			10.98%	17.72%	-46.04%	-		21.22%
Total			2.17B	1.96B	1.74B	1.57B		1.58B
Total Growth			10.81%	12.55%	11.15%	-		-1.94%

Source: S&P Global Market Intelligence.